Follow
Chiara Lanzillotta
Chiara Lanzillotta
Verified email at uniroma1.it
Title
Cited by
Cited by
Year
Oxidative stress, protein modification and Alzheimer disease
A Tramutola, C Lanzillotta, M Perluigi, DA Butterfield
Brain research bulletin 133, 88-96, 2017
3312017
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
A Tramutola, C Lanzillotta, E Barone, A Arena, I Zuliani, L Mosca, ...
Translational neurodegeneration 7, 1-22, 2018
792018
Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies
A Tramutola, C Lanzillotta, F Di Domenico
Expert Review of Neurotherapeutics 17 (1), 33-45, 2017
652017
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome
A Tramutola, C Lanzillotta, F Di Domenico, E Head, DA Butterfield, ...
Neurobiology of Disease 137, 104772, 2020
572020
Targeting mitochondria in Alzheimer disease: rationale and perspectives
C Lanzillotta, F Di Domenico, M Perluigi, DA Butterfield
CNS drugs 33 (10), 957-969, 2019
542019
Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease
N Sharma, A Tramutola, C Lanzillotta, A Arena, C Blarzino, T Cassano, ...
Neurobiology of Disease 125, 176-189, 2019
542019
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome
F Di Domenico, A Tramutola, E Barone, C Lanzillotta, O Defever, A Arena, ...
Redox biology 23, 101162, 2019
532019
Increased mammalian target of rapamycin signaling contributes to the accumulation of protein oxidative damage in a mouse model of Down's syndrome
A Tramutola, C Lanzillotta, A Arena, E Barone, M Perluigi, F Di Domenico
Neurodegenerative Diseases 16 (1-2), 62-68, 2016
392016
Activation of p53 in Down syndrome and in the Ts65Dn mouse brain is associated with a pro-apoptotic phenotype
A Tramutola, G Pupo, F Di Domenico, E Barone, A Arena, C Lanzillotta, ...
Journal of Alzheimer's Disease 52 (1), 359-371, 2016
382016
Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity
FA Cimini, A Arena, I Barchetta, A Tramutola, V Ceccarelli, C Lanzillotta, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1865 (6 …, 2019
362019
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease
A Tramutola, N Sharma, E Barone, C Lanzillotta, A Castellani, F Iavarone, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (10 …, 2018
352018
Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: A harmful synergistic path in down syndrome
C Lanzillotta, A Tramutola, G Di Giacomo, F Marini, DA Butterfield, ...
Free Radical Biology and Medicine 165, 152-170, 2021
312021
Chronic PERK induction promotes Alzheimer-like neuropathology in Down syndrome: Insights for therapeutic intervention
C Lanzillotta, I Zuliani, A Tramutola, E Barone, C Blarzino, V Folgiero, ...
Progress in Neurobiology 196, 101892, 2021
272021
Identification of changes in neuronal function as a consequence of aging and tauopathic neurodegeneration using a novel and sensitive magnetic resonance imaging approach
SN Fontaine, A Ingram, RA Cloyd, SE Meier, E Miller, D Lyons, GK Nation, ...
Neurobiology of aging 56, 78-86, 2017
262017
Stress responses in down syndrome neurodegeneration: state of the art and therapeutic molecules
C Lanzillotta, F Di Domenico
Biomolecules 11 (2), 266, 2021
232021
Protein nitration profile of CD3+ lymphocytes from Alzheimer disease patients: Novel hints on immunosenescence and biomarker detection
A Tramutola, G Abate, C Lanzillotta, F Triani, E Barone, F Iavarone, ...
Free Radical Biology and Medicine 129, 430-439, 2018
222018
Early and selective activation and subsequent alterations to the unfolded protein response in down syndrome mouse models
C Lanzillotta, A Tramutola, S Meier, F Schmitt, E Barone, M Perluigi, ...
Journal of Alzheimer's Disease 62 (1), 347-359, 2018
212018
High-fat diet leads to reduced protein O-GlcNAcylation and mitochondrial defects promoting the development of Alzheimer’s disease signatures
I Zuliani, C Lanzillotta, A Tramutola, E Barone, M Perluigi, S Rinaldo, ...
International journal of molecular sciences 22 (7), 3746, 2021
202021
BVR-A deficiency leads to autophagy impairment through the dysregulation of AMPK/mTOR axis in the brain—Implications for neurodegeneration
C Lanzillotta, I Zuliani, C Vasavda, SH Snyder, BD Paul, M Perluigi, ...
Antioxidants 9 (8), 671, 2020
192020
Therapeutic potential of rescuing protein O-GlcNAcylation in tau-related pathologies
F Di Domenico, C Lanzillotta, A Tramutola
Expert Review of Neurotherapeutics 19 (1), 1-3, 2019
172019
The system can't perform the operation now. Try again later.
Articles 1–20